COMMENTARY: Medicare must study unproven, expensive Alzheimer's drug

Fredericksburg Free Lance Star

Jun 23, 2021

The Food and Drug Administration has approved a drug treatment for Alzheimer's disease that may or may not work, but is set to cost $56,000 a year for the average patient - a charg…